NEW YORK, NY – April 6, 2018 – Academy Award-winning Actress Kathy Bates will lead a group of activists to Capitol Hill on Friday, May 11, 2018, to ask Congress to ensure that $70 million of the National Institutes of Health’s increased budget will be allocated to lymphatic research. They will also advocate for the Department of Defense to include “lymphatic diseases” as a medical research area, and will urge the passage of the Lymphedema Treatment Act (LTA), which would ensure Medicare coverage for medically necessary compression garments.
In an email to Lymphatic Education & Research Network (LE&RN) supporters asking them to head to the Capitol with her, Ms. Bates wrote, “This is our chance to meet with legislative leaders to request support for lymphedema and lymphatic disease research funding.”
The Lobby Day coincides with LE&RN’s first-ever Walk to Fight Lymphedema & Lymphatic Diseases in Washington, D.C. on Saturday, May 12, 2018. Ms. Bates will address participants at the Lincoln Memorial that morning at the start of the Walk.
“This is a very special LymphWalk in D.C. in May,” said William Repicci, LE&RN’s President and CEO. “We’ll be in town to demand research dollars and insurance coverage, and we are fortunate that Kathy Bates will lead our efforts at the Capitol on Friday and at the Lincoln Memorial on Saturday. This year is LE&RN’s 20th anniversary and our presence in D.C. shows how far the movement has come, thanks to the efforts of activists around the country and around the world. We will settle for nothing less than a cure for these diseases which affect 10 million Americans and up to 170 million around the world.”
To sign up to run or walk in support of the 10 million Americans and 170 million worldwide who are battling this lymphedemic™, just register at www.LymphWalk.org. If you would like to attend the LE&RN Lobby Day, please email LE&RN at LERN@LymphaticNetwork.org.
LE&RN thanks National Series Walk sponsors BSN medical (Premier National Sponsor), Tactile Medical (Presenting Sponsor), BioCompression Systems, Juzo, ImpediMed/L-Dex, Eiger BioPharmaceuticals, Sigvaris, MediUSA, Herantis Pharma, L&R USA Inc., LympheDIVAS, and Lympha Press.
Founded in 1998, the Lymphatic Education & Research Network (formerly LRF) is a 501(c)(3) not-for-profit organization whose mission is to fight lymphatic disease and lymphedema through education, research and advocacy. LE&RN provides valuable educational resources for the millions of people who suffer from lymphedema and lymphatic disease. LE&RN fosters and supports research that can deepen the medical community's understanding of the lymphatic system. For more information about lymphatic diseases or the Lymphatic Education & Research Network, please visit www.LymphaticNetwork.org or call (516) 625-9675.